Stockscreener 앱 받기
6.95
2.39%
-0.17
Journey Medical Corp 주식(DERM)의 최신 뉴스
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 - The Manila Times
WallabyPhenox Restructures Debt and Accelerates Global Growth - The Manila Times
Off The Hook Yachts Expands Mid-Atlantic Presence with Strategic Waterfront Hub to Increase Inventory Velocity and Margin Capture - The Manila Times
Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available - The Manila Times
Dermatology drug seller Journey Medical to detail 2025 results on Mar. 25 - Stock Titan
Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Journey Medical Corp expected to post a loss of 6 cents a shareEarnings Preview - TradingView
TENX PE Ratio & Valuation, Is TENX Overvalued - Intellectia AI
DERM Stock Price, Quote & Chart | JOURNEY MEDICAL CORP (NASDAQ:DERM) - ChartMill
Rally Mode: Will Journey Medical Corporation benefit from sector rotationJuly 2025 Macro Moves & Entry Point Confirmation Alerts - baoquankhu1.vn
Journey Medical (NASDAQ:DERM) Shares Down 3.5%What's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Journey Medical Corp (DERM) - The Globe and Mail
10 Best Travel Insurance Companies For 2026 - Forbes
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
DERM PE Ratio & Valuation, Is DERM Overvalued - Intellectia AI
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Support Test: Will RLX Technology Inc Depositary Receipt stock hit new highs in YEARJuly 2025 Outlook & Community Verified Watchlist Alerts - baoquankhu1.vn
Why ORGO stock attracts high net worth investorsNew Guidance & Stock Portfolio Risk Control - mfd.ru
US Market Wrap: Does Senseonics Holdings Inc have declining or rising EPSQuarterly Growth Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Analyst Calls: Will Safety Shot Inc outperform the market in YEARJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - baoquankhu1.vn
What’s the RSI of RVYL stockWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru
How buybacks impact GMAB stock valueQuarterly Portfolio Review & AI Driven Stock Price Forecasts - mfd.ru
DERM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
DERM Should I Buy - Intellectia AI
Gates Industrial (NYSE:GTES) Sets New 52-Week High Following Earnings Beat - Defense World
Journey Medical Corporation (NASDAQ:DERM) Receives $12.17 Consensus Target Price from Brokerages - Defense World
Buyout Rumor: Can Journey Medical Corporation be recession proofJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - baoquankhu1.vn
Insurer Seeks To Cap Coverage In $3M Medical Transport Row - Law360
Insurer Seeks To Cap Coverage In $3M Medical Transit Row - Law360
Essex Investment Management Co. LLC Acquires 125,818 Shares of Journey Medical Corporation $DERM - MarketBeat
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Journey Medical (NASDAQ:DERM) Shares Down 3.7%Here's What Happened - MarketBeat
Patient journey goes digital at Ewha Womans Seoul Hospital - Healthcare IT News
Palmer Township woman’s 20-year journey from cancer survivor to heart health advocate - WFMZ.com
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target - Investing.com Nigeria
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target By Investing.com - Investing.com South Africa
Will Journey Medical Corporation benefit from geopolitical trendsPortfolio Update Summary & Growth Oriented Trading Recommendations - mfd.ru
Value Recap: Can Journey Medical Corporation reach all time highs this year - baoquankhu1.vn
Risk Analysis: Is DUKPRA impacted by rising ratesMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
CVS Health Corp.: How a Pharmacy Giant Is Rebooting Itself as a Healthcare Platform - AD HOC NEWS
Journey Medical Corp entered into sales agreement to offer and sell up to 3.75 million shares of common stock - marketscreener.com
Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView
Journey Medical: Emrosi Is Winning, But The Stock Hasn't Noticed - Seeking Alpha
Published on: 2026-01-20 22:55:08 - baoquankhu1.vn
Does Autonomix Medical Inc meet Warren Buffetts criteriaJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Published on: 2026-01-19 20:20:55 - baoquankhu1.vn
Journey Medical Corp: Small-Cap Dermatology Stock Walks a Tightrope Between Turnaround Hopes and Vol - AD HOC NEWS
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of “Hold” by Analysts - Defense World
Journey Medical Files $150 Million Mixed Shelf - marketscreener.com
CVS Health Corp.: How a Pharmacy Giant Is Rebuilding the Front Door to U.S. Healthcare - AD HOC NEWS
Journey Medical (NASDAQ:DERM) Trading 3.4% HigherHere's What Happened - MarketBeat
WebMD Launches Embody -- A Whole-Self Health, Weight Loss, and Weight Management Platform - The AI Journal
Early ZYCUBO treatment cut death risk nearly 80% in children with Menkes - Stock Titan
CVS Health Corp.: How a Pharmacy Giant Is Re?Engineering the Front Door to U.S. Healthcare - AD HOC NEWS
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data - MSN
Will Journey Medical Corporation stock gain from government policiesJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
2.02%
0.77%
자본화:
|
볼륨(24시간):